CHI3L1 has attracted growing attention as a biomarker of neuroinflammation and microglial activation and reactive astrocytes, two signs both particularly evident and relevant in MS pathogenesis [128]. The gene discussed is CHI3L1; the disease is myeloid sarcoma.